<DOC>
	<DOCNO>NCT00858988</DOCNO>
	<brief_summary>The purpose study determine whether rifaximin effective treatment tropical enteropathy population African child high risk disease .</brief_summary>
	<brief_title>Trial Rifaximin Treatment Tropical Enteropathy</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Sprue , Tropical</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>live single village acutely malnourish acutely ill chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>